Related Experiment Video
Updated: May 4, 2026

07:53
Interphase Fluorescence in situ Hybridization of Bone Marrow Smears of Multiple Myeloma
Published on: April 15, 2022
4.4K
An aggressive hematolymphoid neoplasm with homozygous SMARCB1 loss shows response to EZH2 inhibition
Iman Sarami1, Amy S Duffield2, Suchitra Sundaram3
1Department of Hematopathology, University of Texas MD Anderson Cancer Center, Houston, TX.
Haematologica
|June 26, 2025
Abstract
No abstract available in PubMed .

